Sanofi SA (NAS:SNY)
$ 48.69 0.6274 (1.31%) Market Cap: 121.69 Bil Enterprise Value: 132.17 Bil PE Ratio: 21.67 PB Ratio: 1.57 GF Score: 84/100

Sanofi SA at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 24, 2021 / 08:00PM GMT
Release Date Price: $46.61 (+0.43%)
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst

Good afternoon, everybody. Welcome to our next company session at the Global Healthcare Conference. I'm delighted to welcome Sanofi to the GHC this year. Sanofi is represented by Dietmar Berger, who is Chief Medical Officer and Global Head of Product Development at Sanofi. Dietmar, thank you so much for joining us.

Dietmar P. Berger
Sanofi - Chief Medical Officer & Global Head of Development

Thank you, Geoff. Thanks for having me.

Questions & Answers

Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst

So a lot going on at Sanofi. We just came out of the Capital Markets Day. Perhaps you could just give us a sense of sort of what the largest development programs now going on at Sanofi are? And just help us understand where you're allocating your resources,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot